Search

Your search keyword '"Kim, Brian S"' showing total 651 results

Search Constraints

Start Over You searched for: Author "Kim, Brian S" Remove constraint Author: "Kim, Brian S"
651 results on '"Kim, Brian S"'

Search Results

1. Good plasmons in a bad metal

2. Author Correction: Hyperbolic exciton polaritons in a van der Waals magnet

3. An IL-4 signalling axis in bone marrow drives pro-tumorigenic myelopoiesis

4. Atomically imprinted graphene plasmonic cavities

5. Infrared Plasmons Propagate through a Hyperbolic Nodal Metal

7. Ambipolar charge-transfer graphene plasmonic cavities

9. Hyperbolic exciton polaritons in a van der Waals magnet

13. IL-33 potentiates histaminergic itch

14. Sensory neurons promote immune homeostasis in the lung

20. Perfect timing: circadian rhythms, sleep, and immunity — an NIH workshop summary

21. A human STAT3 gain-of-function variant drives local Th17 dysregulation and skin inflammation in mice

24. Double-Side-Doped 2D TMD FET Channel

25. RAG suppresses group 2 innate lymphoid cells

26. Dupilumab improves pruritus and skin lesions in patients with prurigo nodularis: Pooled results from two phase 3 trials (LIBERTY-PN PRIME and PRIME2)

29. Humans are unreliable models of mouse disease.

30. A phase 2a study investigating the effects of ritlecitinib on brainstem auditory evoked potentials and intraepidermal nerve fiber histology in adults with alopecia areata.

31. High carrier mobility in graphene doped using a monolayer of tungsten oxyselenide

32. Transfer of Cell-Surface Antigens by Scavenger Receptor CD36 Promotes Thymic Regulatory T Cell Receptor Repertoire Development and Allo-tolerance

34. 529 - Worsening of itch before flaring in patients with moderate-to-severe atopic dermatitis treated with abrocitinib: a post hoc analysis of the phase 3 JADE REGIMEN trial

35. 512 - Dupilumab treatment improves satisfaction in patients with prurigo nodularis who did not achieve the multicomponent endpoint: analysis from LIBERTY-PN PRIME and PRIME2

36. 510 - Dupilumab is efficacious in patients with prurigo nodularis regardless of stable use of topical corticosteroids and topical calcineurin inhibitors: pooled results from two phase 3 trials (LIBERTY-PN PRIME and PRIME2)

37. 542 - Validation of the skin pain numerical rating scale of the Pruritus and Symptoms Assessment for Atopic Dermatitis for adults and adolescents with moderate-to-severe atopic dermatitis

39. Rapid Reduction and Free or Almost Free of Itch Response With Oral Difelikefalin in Subjects With Notalgia Paresthetica and Moderate-to-Severe Pruritus

43. ATOPIC DERMATITIS: Five things to know

44. Intercellular Mitochondria Transfer to Macrophages Regulates White Adipose Tissue Homeostasis and Is Impaired in Obesity

50. Abrocitinib Provides Rapid and Sustained Improvement in Skin Pain and Is Associated With Improved Quality of Life Outcomes in Adult and Adolescent Patients With Moderate-to-Severe Atopic Dermatitis

Catalog

Books, media, physical & digital resources